PHOENIX, Feb. 20, 2020 — SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today the appointment of Steve Krause as Executive Vice President of Sales and Marketing.
Most recently, Mr. Krause was Global Business Director at Valent BioSciences where he led their work in commercializing bio-pest solutions for the global market. Steve has a B.S. in Biology, an M.B.A. in Management and a Ph.D. in Entomology, and has experience in both government agencies and the private sector.
Ken Siegel, SenesTech’s CEO, commented, “Steve has a proven track record of success in developing markets, and specifically marketing and selling innovative, biorational product solutions into the pest control industry, and is eager to bring his experiences to SenesTech as we aggressively expand our sales and marketing efforts.”
Steve Krause continued, “I am very excited to be joining SenesTech at this time. ContraPest® offers a new paradigm in pest control, which is not an industry that easily embraces innovation or change without good reason. By focusing on customer-centric, I am confident that the SenesTech team can provide that reason and successfully advance ContraPest.”
About SenesTech
SenesTech is changing the paradigm of pest management by targeting one of the root causes of the problem: reproduction.
ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly.
We believe ContraPest® will establish a new paradigm in rodent control, resulting in a decreased reliance on lethal options. For more information visit the SenesTech website at www.senestech.com.
Safe Harbor Statement
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan” or “planned,” “will” or “should,” “expected,” “anticipates,” “draft,” “eventually” or “projected.” You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. Forward looking statements include, but are not limited to, our expectation regarding sales commitments, our expectation regarding the conversion of sales commitments and programs to revenue, our belief that our product is more humane, less harmful to the environment and more effective than traditional methods, and our belief that ContraPest will establish a new paradigm in rodent control without environmental effects of rodenticides. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
CONTACT:
Investor: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download multimedia:http://www.prnewswire.com/news-releases/steve-krause-joins-senestech-as-evp-of-sales-and-marketing-301007759.html
SOURCE SenesTech, Inc.